Hyperspectral Imaging System Market Expects An Extensive Growth In Roi Till 2025

 Global Hyperspectral Imaging System Market held a value of USD 10,700 Million in 2018, at a CAGR of 17.4% during the assessment period of 2019 to 2025.

Hyperspectral Imaging System Market Synopsis

Hyperspectral Imaging Systems (HIS) are also known as imaging spectroscopy. It was originated from remote sensing and has various applications in surveillance, remote sensing, machine vision/optical, and medical diagnostics. It can acquire 2D images across a wide range of the electromagnetic spectrum. Increasing applications for research in life sciences and the medical diagnostics sector in the past few years are responsible for a surge in demand for hyperspectral imaging systems. The key players involved in this market are actively focusing upon building partnerships, collaborations, and joint ventures with hospitals and ambulatory centers to strengthen their position in the market. Moreover, there is an increasing growth in various chronic diseases, which pushes the need for efficient hyperspectral imaging systems in the developing as well as underdeveloped regions.

Hyperspectral Imaging System Market Influencer

Rising funding and investments for the development of hyperspectral medical imaging systems are likely to provide favorable conditions for the growth of the hyperspectral medical imaging system market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8741

Hyperspectral Imaging System Market Drivers

• The growing industrial applications of hyperspectral imaging is anticipated to drive the growth of the market during the forecast period. It has various applications in food & agriculture, healthcare, defense, mining, and metrology industries.
• Innovative and easy to use product launched in recent years
• Rising spending on scientific research and aerospace industry
• The growing prevalence of cancer and increasing awareness of innovative diagnostics methods is providing favorable conditions for the growth of the market during the forecast period. According to the US Department of Health and Human Services, 1,735,350 new cases of cancer were detected in the US in 2018. It is expected to accelerate the demand for hyperspectral imaging systems during the study period
• High investment in research and development for the development of efficient imaging solutions

Market Restraints

• High costs associated with HIS are likely to hamper the market growth
• Data storage-related issues associated with HIS

Hyperspectral Imaging System Market Segmentation

By Product

• Visible/Near-Infrared (VNIR): These systems create a false-color composite image made using near-infrared, green, and blue wavelengths. They are used in healthcare and agriculture sectors. VNIR segment is estimated to hold the largest market share during the forecast period due to the ease in operating and high efficiency of VNIR products
• Mid-Wave Infrared (MWIR): Mid-Wave Infrared (MWIR) systems operate in wavelengths ranging from 3µm to 5µm (3000nm to 5000nm). This segment is anticipated to be the fastest-growing segment owing to the rising adoption of MWIR systems in detecting volcanic vents, industrial gas leaks, or biomass burning events.
• Short-Wave Infrared (SWIR): It operates in wavelengths between 1,050 and 2,500 nm and used in inspection, sorting, and quality control. It has various applications including surveillance and remote sensing.
• Long-Wave Infrared (LWIR): Long-Wave Infrared (LWIR) systems are used in the detection of minerals such as quartz, adularia, albite, kaolinite, orthoclase, Na- and Ca-montmorillonite, calcite, opal, chalcedony, gypsum, alunite, jarosite, and other sulfates.

By Technology

• Pushbroom: These devices are made up of digital micromirror devices (DMD), CMOS image sensors. It is also called a line scan. This segment is estimated to hold maximum market share during the forecast period. The growth of this segment is attributed to the growing popularity of push broom systems in computer vision, remote sensing, biomedicine, surveillance, precision agriculture, environmental studies, forensics, nanoparticle research, food science, mining, forestry, etc.
• Snapshot: Snapshot hyperspectral imagers are fast as compare to other systems. This segment is expected to register the fastest CAGR during the forecast period.
• Others: Others include whiskbroom, tunable filter, and other technologies.

By Application

• Surveillance: The majority of the hyperspectral imaging systems are used for defense and surveillance. Additionally, it can detect satellites, high-altitude reconnaissance aircraft, medium-altitude commercial aircraft, and drones. The market growth of the segment is majorly attributed to the increasing adoption of innovative technologies in the defense sector, along with the rising applications of unmanned aerial vehicles for surveillance purposes.
• Medical Diagnostics: Medical diagnostics segment is anticipated to be the fastest-growing segment owing to the increasing applications of the hyperspectral imaging system in healthcare, such as the detection of the chemical composition of human tissues. Additionally, it has potential applications in non-invasive diagnosis.
• Remote Sensing: Remote sensing is likely to hold significant market share in the global hyperspectral imaging system market. It is also known as imaging spectroscopy. It is used for the detection and identification of minerals, terrestrial vegetation, and human-made materials and backgrounds.
• Machine Vision/Optical: Various hyperspectral imaging systems are used for machine vision/optical purposes.

By Region

• Americas: Americas is estimated to be the largest regional market owing to the presence of prominent players in the major countries in America. Major market players such as Headwall Photonics, Inc., Resonon, Inc., Corning Incorporated, Applied Spectral Imaging, and Surface Optics Corporation have a significant presence in the Americas. The region is anticipated to dominate the global hyperspectral imaging system market owing to the well-established healthcare sector and rising healthcare spending in the region. According to the Committee for a Responsible Federal Budget, in 2017, the US has spent more than USD 3.5 trillion on healthcare-related expenses.
• Europe: The European region holds the second largest share as there is increasing support from regulatory authorities to control cancer. Moreover, the rising expenses on defense and surge in demand for innovative and easy to use hyperspectral imaging systems have led to an increase in demand for hyperspectral imaging systems in the region.
• Asia-Pacific: The Asia-Pacific region is anticipated to be the fastest-growing region in the global hyperspectral imaging system market. This region is witnessing a surge due to the increasing mining activities, and growing biotechnology and agriculture sector in developing countries such as India. According to the India Brand Equity Foundation, the Indian biotechnology sector is likely to reach around USD 12 billion in the year 2018. The growing biotechnology sector is likely to provide favorable conditions and anticipated to drive growth in the market.
• Middle East & Africa: The smallest market due to limited healthcare infrastructure and limited exposure to innovative solutions.

Key Players

• Headwall Photonics, Inc.
• Specim, Spectral Imaging Ltd.
• Norsk Elektro Optikk as (NEO)
• Resonon, Inc.
• Corning Incorporated
• Telops
• Applied Spectral Imaging
• Bayspec, Inc.
• Surface Optics Corporation
• Chemimage Corporation
• Cubert GmbH
• Raytheon
• Galileo Group, Inc.
• Hypermed Imaging, Inc.
• Inno-Spec
• Camlin Group Ltd.
• IMEC
• XIMEA GmbH
• Others 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hyperspectral-imaging-system-market-8741

Global Gene Panel Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2020-2025

 Market Scenario

The increasing prevalence of chronic diseases such as cancer, genetic diseases, and rare diseases, increase in adoption of genetic testing, rising company initiatives, technological advancements, need for efficient prenatal diagnosis, and increasing health awareness are estimated to drive the market during the forecast period. However, factors such as expensive tests, inaccuracy in results, and security concerns of the genes are estimated to restrain the market growth during the forecast period.

Global Gene Panel Market size is expected to register a CAGR of 12.16% to reach USD 4,347.32 Million by 2025.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6100

Segmentation

The global gene panel market is segmented on the basis of product and service, technique, design, application, and end-user. The gene panel market, by product and service, is segmented into test kits and testing services. The global gene panel market by technique is segmented into the amplicon-based approach and hybridization-based approach. The design segment is segmented into predesigned gene panels and customized gene panels. On the basis of application, the market is categorized into cancer risk assessment, pharmacogenetics, diagnosis of congenital disorders, and other applications. The cancer risk assessment segment is further sub-segmented into syndrome-specific gene panels, high-penetrance gene panels, high and moderate-penetrance gene panels, and comprehensive cancer risk panels. On the basis of end-user, the market is categorized into hospitals, diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies.

Key players

Some of the key players for the global gene panel market are Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Illumina, Inc., BGI (China), Agilent Technologies (US),  Integrated DNA Technologies (IDT) (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Novogene Corporation (China), Personalis (US), GATC Biotech AG (GATC Biotech) (Germany), ArcherDx (US), GeneDx., CENTOGENE AG, and others.

Regional Market Summary

The Americas dominates the global market for gene panel. The increase in the patient pool for chronic diseases, government initiatives for the development of cancer treatment, and presence of strong market players such as Thermo Fisher Scientific drive the market growth in this region. Europe (the U.K., Belgium, France, and the Netherlands) is second in the market owing to the increasing research and development activities for cancer and congenital diseases. Also, the high occurrence rate of cancer in Europe influences the market growth in Europe. According to WHO, there are 3.7 million cases of cancer in Europe every year. Furthermore, Germany is predicted to dominate the European market as there were 2, 24,089 number of deaths due to cancer in 2014. Also, technological advancements coupled with an early diagnosis of cancer is likely to drive market growth for gene panel in Germany. Asia Pacific is expected to observe growth for the global gene panel market owing to the growing prevalence of cancer and increasing health expenditure. The Middle East and Africa with the presence of low-income countries, low healthcare expenditures, and stringent government regulations accounted for the least market share.

Browse More Medical Device Reports @  https://www.marketresearchfuture.com/reports/gene-panel-market-6100 

Facial Fat TransferMarket Up To 2025: Top Companies, Growth Factors Details And Regional Overview By Types & Application

 Market Highlights

Facial Fat Transfer Market is estimated to be valued at USD 7789.1 Million by 2025 and is expected to register a CAGR of 11.05% during the forecast period.

Facial fat transfer is a minimally invasive surgical procedure to move fat from an area of the body where it is plentiful and transfer it to the face to restore lost volume. The fat is gently removed using modern liposuction techniques and is then prepared for injecting into the face. Several dermal fillers are available in the market, designed to improve different parts of the face.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1780 

Segment Analysis

The Global Facial Fat Transfer Market has been segmented based on the target area, Treatment, End-User, and Region. Based on the target area, the market has been divided into naso-labial folds, lips, marionette folds, temples, chin, and under-eye area. Based on treatment, the market is further sub-segmented as dermal fillers, fat injections, and others. On the basis of end user, the market has been divided into hospitals, cosmetic surgery clinics, and others.

Regional Analysis

Geographically, the Global Facial Fat Transfer Market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, Americas were the largest market for facial fat transfer in 2018 and is expected to remain dominant during the review period. Increasing awareness regarding body aesthetics and the introduction of advanced technology in the facial rejuvenation industry are major factors that drive the growth of the facial fat transfer market in the American region.

Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing demand for minimally invasive cosmetic procedures is fueling the facial fat transfer market growth in European countries. For instance, according to the British Association of Aesthetic Plastic Surgeons, in London, 2019, over 28,000 cosmetic procedures took place in 2018.

The market in Asia-Pacific is expected to register a significant growth rate during the forecast period. The majority of the companies in Asia-Pacific are committed to investing in research and development of facial fat transfer treatments, which will ultimately boost the growth of the market.

The growth of the Middle East and Africa facial fat transfer market is majorly attributed to developing healthcare infrastructure, and continuously increasing demand for facial fat transfer products. Africa holds the least share of the market due to the limited availability of funds and medical facilities

Market Players

Market Research Future (MRFR) recognizes DR. Korman (Israel), Galderma Laboratories, L.P. (US), Integra LifeSciences Corporation (Israel), Merz Pharma (Germany), Allergan (Ireland), SciVision Biotech Inc (Taiwan), Suneva Medical, Inc (US), Bausch Health Companies Inc (Canada), Teoxane Laboratories (Switzerland), Ipsen Pharma (France), Sinclair Pharma (UK) as the key players in the Global Facial Fat Transfer Market.

Key Findings of the Study:

• The Global Facial Fat Transfer Market is projected to reach over USD 7789.1 Million by 2025 at an 05 % CAGR during the review period of 2019 to 2025.
• North America accounted for the largest market share, with the US being the major contributor to the growth of the market.
• Based on the target area, the naso-labial folds segment is projected to register the highest CAGR of 11.51% during the forecast period owing to the rising prevalence of facial fat transfer cases.
• On the basis of treatment, the dermal fillers segment accounted for the largest market share of 49.76% in 2018.
• Based on end user, the hospitals segment accounted for the largest market share of 49.20% in 2018

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/facial-fat-transfer-market-1780 

The Thoracolumbar Spine Devices Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2025

 Market Highlights

Thoracolumbar Spine Devices Market is expected to register a CAGR of3.72% during the forecast period, with a market value of USD 8,484.7 Million till 2025. The human spinal cord, based on anatomy, is divided into three sections, namely cervical, thoracic, and lumbar. The cervical section is located at the beginning of the skull comprising of the first seven vertebrae. The thoracic spine is the midback consisting of the next 12 vertebrae, and the section from ribs to sacrum comprises the lumbar section consisting of the five lower vertebrae.

The increasing obese population, high prevalence of spinal cord injuries (SCI), and increasing geriatric population are expected to enhance the market growth. However, the stringent regulatory policies, lack of awareness for the use of advanced technologies, and product recalls are projected to curb the growth of the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/5657

Segment Analysis

The global thoracolumbar spine devices market, by product type, has been segmented into spinal implants, devices and instrumentation, and spine biologics. Based on type of surgery, the Thoracolumbar spine devices market has been categorized as open surgery and minimally invasive surgery (MIS). The by material segment is further segmented as titanium, stainless steel, biomaterials, and others. Based on end user, the thoracolumbar spine devices market has been categorized as hospitals and clinics, ambulatory surgery centers, academic institutes and research centers, and others.

Regional Analysis

The Global Thoracolumbar Spine Devices Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The existence of medical device companies, developed healthcare infrastructure, significant per capita healthcare spending, high funding for research & development projects, focused researches in spine disorders along with grants from government healthcare agencies, and high adoption of advanced medical technologies in the US and Canada are likely to support the dominance of the Americas during the forecast period.

Europe is anticipated to account for the second-largest market share during the forecast period. The market growth in Europe can be attributed to factors such as the increasing number of individuals affected by spinal cord injuries. For instance, according to the Association for Spinal Injury Research, Rehabilitation, and Reintegration, the number of people diagnosed with a spinal cord injury in the UK is 2500 per year.

Asia-Pacific is likely to be the fastest-growing region in the global thoracolumbar spine devices market. The growing geriatric population and booming medical tourism sector in India, China, Australia, and Malaysia are likely to impact the regional market growth during the forecast period. According to the United Nations Department of Economic and Social Affairs (UN DESA), in 2017, 12% of the population in Asia and 17% in Oceania was aged 60 or above, which is projected to increase to 24% and 23%, respectively by 2050. This elderly population is more prone to develop thoracolumbar spine disorders, which are fostering market growth. India held a share of 16.2% in the Asia-Pacific thoracolumbar spine devices market in 2018.

The Middle East & Africa market is projected to show gradual growth during the forecast period. In this region, the Middle East is anticipated to dominate owing to factors like increasing growth in the medical tourism sector. For instance, according to the Dubai Health Authority (DHA), in 2016, the medical tourism sector showed a significant growth of 9% to 10%, and more than 326,649 patients from all over the world visited Dubai for medical treatments.

Market Players

MRFR recognizes the following companies as the Key Players in the Global Thoracolumbar Spine Devices Market—Orthofix Holdings, Inc. (US), Alphatech holdings, Inc. (US), B. Braun Melsungen AG (Germany), Depuy Synthes (US), Exactech, Inc. (US), Globus Medical, Inc. (US), Medtronic Plc (Ireland), NuVasive, Inc. (US), ZIMMER BIOMET HOLDINGS, INC. (US), and STRYKER CORPORATION (US).

Key Findings of the Study

·The Global Thoracolumbar Spine Devices Market was valued at USD 6,531.2 million in 2018 and is estimated to grow to USD 8,484.7 Million by 2025 at a CAGR of 3.72% during the assessment period

·The Americas accounted for the largest share of the global market due to the presence of key market players, sophisticated healthcare infrastructure, and increasing R&D in the field of thoracolumbar spine devices.

·Based on product type, the spine biologics segment accounted for a market share of 23.5% in 2018

·On the basis of the end user, the hospitals and clinics segment dominated the market and accounted for a share of 48.7% in 2018

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/thoracolumbar-spine-devices-market-5657

Biochips Market is expected to rise at a remarkable CAGR By 2023

 Global Biochips Market trends held a market value of USD 7,300 million in 2017, according to the MRFR. The market is expected to exhibit a strong 16.6% CAGR over the forecast period from 2018 to 2023, according to the report.

Biochips are intended to function in biological environment, preferably inside living organism. The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications will boost the biochips market size and growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.  

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7063

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease. 
Competitive Landscape:
Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics are some of the prominent players in the global biochips market.

Segmentation:
The Global Biochips Market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.  

The Middle East & Africa has the lowest biochips market share in global market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/biochips-market-7063

Surgical Drills Market is expected to rise at a remarkable CAGR By 2023

 Surgical drills as the name itself suggests, are drill machines which are used during the various surgical procedures. Their main function is to drill, cut, and bore holes in the bone in order to attach surgical pins, plates, or screws. There are several types of surgical drills available which are powered by different source. These include pneumatic drills, electric drills, and battery powered drills among others. Surgical drills have simplified the tedious job of a surgeon and reduced the surgery time significantly. Surgical drills have become an important tool in the surgical procedures. Due to high surgical drills market demand and Increasing number of orthopedic and dental surgeries, high awareness about the dental hygiene and high disposable income are some of the factors contribute to the growth of the surgical drills market share.

Key players:

Adeor medical AG, AlloTech Co.Ltd. Arthrex Inc., B.Braun Melsungen AG, CONMED Corporation, De Soutter Medical, DePuy Synthes, Medtronic plc, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key players in the global surgical drills market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7035

Segmentation:
The Global Surgical Drills Market has been segmented into product, application and end-user.Based on products, the market has been segmented into, pneumatic drills, electric drills, battery powered drills, accessories, and others. The pneumatic drills segment is expected to account for the largest share in the global surgical drills market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other products. Based on application, the market has been segmented into orthopedic surgery, neurosurgery, ENT, dental surgery, and other. The orthopedic surgery segment is expected to account for the largest share in the global surgical drills market in 2017 followed by dental surgery segment.Based on end-users, the market has been segmented into hospitals & clinics, ambulatory surgical centers, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global surgical drills market in 2017. At the same time, the increasing establishments of the ambulatory surgical centers in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical drills is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drills market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.European surgical drills market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The surgical drills market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drills market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global surgical drills market owing to the rising number of the orthopaedic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical drills market in this region.

Europe is expected to hold the second largest market share in the global surgical drills market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical drills market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical drills market during the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-drills-market-7035

Animal Genetics Market: Information, Analytical Insights and growth of 2020 – 2023

 Animal Genetics Market Overview

According to the Market Research Future (MRFR) analysis, the global animal genetics market size is estimated to register a CAGR of 8.4% from 2018 to 2023 (forecast period). The report offers an in-depth overview of the industry, including production, suppliers, quality, consumption, growth rate, profit margins, services, imports and exports, and technology advancements.

Animal genetics is a field of genetics that is dedicated to the study of genetic variability and inheritance, especially for domestic and wild animals. For commercial purposes, animal genetics is used for DNA typing, genetic disease testing, and genetic trait testing. This methodology uses a hybrid population, ontogenetic, and cytological studies to determine genetic hybridizations. For example, genetically modified cows may be able to produce more milk and may be less vulnerable to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thereby increasing the overall income of cattle farmers. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7004

Animal Genetics Market Dynamics  

The significant factor responsible for influencing this market is the increase in the consumption of animal-derived protein, the growth of the global population, and rapid urbanization. The increasing focus on the identification of superior breeds has contributed to the growth of the market for toxicology testing. 

However, factors such as the substantial cost of animal testing, the stringent regulatory framework for genetic engineering, and the lack of qualified professionals are expected to inhibit the market growth during the forecast period. 

Animal Genetics Market Segmentation

The global market for animal genetics market is segmented based on animal genetic products, services, and end-users. 

Based on animal genetic products, the global market for animal genetics market is segmented into genetic materials and live animals. The live animals are further divided into poultry, bovine, porcine, canine, and others. The genetic materials are sub-segmented into semen and embryo. 

Based on services, the global market for animal genetics is segmented into genetic disease tests, DNA typing, gene trait tests, and others. 

Based on end-user, the global market for animal genetics is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others. 

Animal Genetics Market Regional Analysis

Regionally, the global animal genetics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global market for animal genetics in 2017. This was due to the growth in the North American region, primarily due to factors such as growing demand for animal products such as pork and mutton. Moreover, rapid urbanization is likely to spur market demand for live animals in the coming years. Growing adoption of artificial insemination, particularly in cattle, sheep, pigs, and goats, is fueling the market growth.

Europe was the second-largest region for the global animal genetics market. Due to rising awareness of animal health, the increase in the number of numerous animal genetic diseases, and the increased prevalence of the zoonotic disease is projected to provide this market with profitable growth opportunities.

The Asia Pacific was expected to be the fastest-growing area on the global market for animal genetics in 2017. Factors due to the increasing population of livestock and the development of DNA typing and genetic testing methods further increase the demand for genetic trait tests and various diagnostic tests. 

Animal Genetics Market Key players

Some of the major participants in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), Groupe Grimaud (France), Animal Genetics (US), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), EW Group (Germany), Envigo (US) Hendrix Genetics BV (The Netherland), Alta Genetics (US), vetGen (US), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004